Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
XNPT > SEC Filings for XNPT > Form 8-K on 14-Jun-2013All Recent SEC Filings

Show all filings for XENOPORT INC | Request a Trial to NEW EDGAR Online Pro

Form 8-K for XENOPORT INC


14-Jun-2013

Costs Associated with Exit or Disposal Activities


Item 2.05 Costs Associated with Exit or Disposal Activities.

On June 13, 2013, the board of directors of XenoPort, Inc. ("XenoPort," or the "Company") committed to implementing a reduction in force that includes the elimination of certain non-executive positions as the Company completes certain work projects on its arbaclofen placarbil development program. The Company notified the employees affected by the reduction in force on June 14, 2013. Pursuant to the XenoPort Amended and Restated 2012 Severance Plan (the "2012 Severance Plan"), a non-executive employee terminated by the Company because of elimination of his or her position is eligible to receive continuation of medical insurance under COBRA and specified severance payments based on the employee's level and years of service with the Company.

The Company estimates that it will incur total charges of approximately $1.2 million in the second quarter of 2013 in connection with the restructuring, including approximately $0.7 million related to severance and other one-time termination benefits and approximately $0.5 million in continuation of salary and benefits of certain employees until their work is completed and their positions are eliminated. The Company expects that all such work will be completed and positions eliminated by October 31, 2013. The Company expects that the associated cash payments of approximately $1.2 million will be paid out commencing in the second quarter of 2013 and will be completed in the first quarter of 2014. The estimates of total charges and cash expenditures that the Company expects to incur in connection with the workforce reduction, and the timing thereof, are subject to a number of assumptions, and actual results may materially differ.

This Current Report on Form 8-K contains "forward-looking" statements, including, without limitation, statements related to the estimated charges for the reduction in force, including related estimated cash expenditures, and the timing for the completion of the reduction in force. Any statements contained in this Current Report on Form 8-K that are not statements of historical fact may be deemed to be forward-looking statements. These forward-looking statements are based upon the Company's current expectations. Forward-looking statements involve risks and uncertainties. The Company's actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, without limitation, the risk that restructuring costs may be greater than currently anticipated, and risks related to the impact of the workforce reduction on the Company's business and unanticipated charges not currently contemplated that may occur as a result of the reduction in force. The Company's Quarterly Report on Form 10-Q, filed with the SEC on April 24, 2013, contains under the heading, "Risk Factors," a more comprehensive description of risks to which the Company is subject. The Company expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company's expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based.


  Add XNPT to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for XNPT - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.